(Q36575361)

15 August 2017

The cost-utility of maintenance treatment with venlafaxine in patients with recurrent major depressive disorder (English)

1 reference

15 August 2017

P Sobocki

1

1 reference

15 August 2017

M Ekman

2

1 reference

15 August 2017

A Ovanfors

3

1 reference

15 August 2017

R Khandker

4

1 reference

15 August 2017

B Jönsson

5

1 reference

15 August 2017

15 February 2008

1 reference

International Journal of Clinical Practice

15 August 2017

1 reference

15 August 2017

62

1 reference

15 August 2017

4

1 reference

15 August 2017

623-632

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

15 August 2017

1 reference

Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Remission from depression : a review of venlafaxine clinical and economic evidence

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

The economic burden of depression in the United States: how did it change between 1990 and 2000?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Prevention of relapse and recurrence in depression: the role of long-term pharmacotherapy and psychotherapy.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Clinical guidelines for the treatment of depressive disorders. II. Principles of management

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Suicide as an outcome for mental disorders. A meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

The effect of episodes on recurrence in affective disorder: a case register study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Assessment of clinical guidelines for continuation treatment in major depression

28 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1742-1241.2008.01711.X

Resource use and costs associated with patients treated for depression in primary care.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Model to assess the cost-effectiveness of new treatments for depression

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

The mission is remission: health economic consequences of achieving full remission with antidepressant treatment for depression.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

The burden of major depression avoidable by longer-term treatment strategies.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Cost of lost productive work time among US workers with depression.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Swedish population health-related quality of life results using the EQ-5D.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Recovery from depression, work productivity, and health care costs among primary care patients

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Multiple recurrences of major depressive disorder.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Recurrence after recovery from major depressive disorder during 15 years of observational follow-up.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Cost utility analysis of maintenance treatment for recurrent depression.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2327222

Recurrence of bipolar disorders and major depression. A life-long perspective

20 September 2018

1 reference

12 December 2020

The value of medical spending in the United States, 1960-2000

1 reference

12 December 2020

US and UK health economics: two disciplines separated by a common language?

1 reference

12 December 2020

Continuation and maintenance therapy in depression

1 reference

12 December 2020

Handling uncertainty when performing economic evaluation of healthcare interventions

1 reference

12 December 2020

[Health services need knowledge of how the public values health]

1 reference

12 December 2020

Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation

1 reference

12 December 2020

Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association

1 reference

12 December 2020

Economic assessment of a maintenance treatment strategy in prevention of recurrent depressive disorder

1 reference

12 December 2020

Cost effectiveness of fluvoxamine in the treatment of recurrent depression in France

1 reference

12 December 2020

10.1111/J.1742-1241.2008.01711.X

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

18284439

1 reference